drugset / Trial / NCT02669784

Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study

NCT02669784

Completed 34 enrolled Milton S. Hershey Medical Center
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of the study is to determine if the dose of contrast (Omnipaque) administered for Computed Tomography Arteriograms (CTA) can be reduced without degradation of image quality. The hypothesis is that there is no difference in image quality using ultra-low dose contrast in CTA exams compared to routine, standard of care dose exams.

Timeline

Start
2016-02
Primary completion
2017-05
Completion
2018-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iohexol Diagnostic / imaging agent 40 ml
Comparator Iohexol Diagnostic / imaging agent 50 ml